Cvs Health is a healthcare plan company located in Rhode Island, United States, which is part of the Healthcare sector, and is traded under the ticker CVS on the NYSE exchange.
Cvs Health stock last closed at $82.01, down 1.24% from the previous day, and has increased 44.26% in one year. It has overperformed other stocks in the Healthcare Plans industry by 0.62 percentage points. Cvs Health stock is currently +88.27% from its 52-week low of $43.56, and -1.81% from its 52-week high of $83.52.
As of Oct 22, 2025, there are 1.27B shares of CVS outstanding. The market capitalization of CVS is $104.02B. In the past 24 hours, 6.36M CVS shares were traded.
You need an online brokerage account to access the NYSE market and buy CVS shares.
Based on our analysis, eToro is the best brokerage. Here's why:
Get $10 towards your share purchase by opening an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've selected the right brokerage, you need to fill out some personal info so you are able to invest in CVS stock today.
Now that you have created your account on the best stock trading app for beginners, you need to deposit funds:
Watch this video walkthrough if you need help depositing money into your new brokerage account.
After you have figured out the best place to buy Cvs Health stock, it's important to research their stock prior to investing, so you actually wrap your head around the risk as well as the opportunity.
WallStreetZen was built to help everyday investors perform more accurate fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on CVS's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge CVS's true value.
Using relative valuations ratios:
You can do more valuation analysis on CVS's stock here.
Out of 12 Wall Street analysts who give forecasts on CVS, the consensus analyst rating on Cvs Health is a Strong Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.
Andrew Mok, a top 18% analyst from Barclays maintains CVS with a strong buy rating and raises their CVS price target from $80.00 to $87.00, on Sep 4, 2025.
Sarah James, a bottom 1% analyst from Cantor Fitzgerald reiterates CVS with a strong buy rating and maintains their CVS price target from $78.00 to $78.00, on Aug 26, 2025.
Kevin Caliendo, a top 17% analyst from UBS upgrades CVS to a strong buy rating and raises their CVS price target from $67.00 to $79.00, on Aug 18, 2025.
UBS's Kevin Caliendo upgraded their rating on Cvs Health (NYSE: CVS) from Hold to Strong Buy on 2025/08/18. The analyst also raised their price target by 17.9% from $67 to $79.
Having had just about three weeks to digest CVS Health's Q2 2025 earnings report, released on 2025/07/31, Caliendo hiked their price target.
According to the analyst, the company has been posting solid quarterly execution numbers, and there are early indications that its healthcare benefits segment fixes are making progress.
Caliendo predicted that CVS Health will have annual earnings growth of 14% from 2018 to 2028, which is higher than the Street estimate of 12%.
Further, the analyst said they see a "compelling valuation" at current share levels.
Michael Ha, a bottom 7% analyst from Baird upgrades CVS to a buy rating and raises their CVS price target from $71.00 to $82.00, on Aug 14, 2025.
Brian Tanquilut, a top 14% analyst from Jefferies maintains CVS with a strong buy rating and raises their CVS price target from $74.00 to $80.00, on Jun 30, 2025.
You can dive deeper into what analysts are forecasting on the Cvs Health stock forecast page.
Last year, CVS earnings were $4.53B. Over the last 5 year, CVS's earnings have gone up by -10.65% per year. This was slower than the Healthcare Plans industry average of 1.76%.
Last year, CVS revenue was $386.64B. In the last 5 year, CVS's revenue has grown by 7.95% per year. This was slower than the Healthcare Plans industry average of 11.54%.
Dig into CVS's earnings and revenue performance here.
Over the past year, executives and large shareholders at CVS have sold more shares than they have bought.
Tilak Mandadi, EVP Chief Exp Tech Officer of CVS, was the latest CVS insider to sell. They sold $938,807.10 worth of CVS stock on Aug 31, 2025.
Get more info about who owns CVS stock here.
Cvs Health pays a dividend of 0.81%, compared to the Healthcare Plans industry's average dividend yield of 1.5%. If you owned $1,000 of CVS stock, you would have been paid $8.11 in the past year.
Cvs Health dividend payments have consistently grown over the past decade and have remained stable.
Find more info about Cvs Health dividend yield and history here.
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
You have two primary order types:
Click the Open button and your broker will execute the order.
If you want additional help buying stocks on eToro, click the how to video below:
Now that you own some CVS shares, you'll want to keep up with your company.
Add CVS to a watchlist to get notified of the latest news about your CVS stock.
To reiterate, here are the 6 steps you need to take to buy Cvs Health stock right now:
If you are looking for a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Cvs Health, add CVS to your watchlist by clicking the button below.